Financial statements Endokrynologia

Balance sheet of Endokrynologia

Company age:
Age:
24 y. 1 m. 26 d.
Share capital:
Share capital:
4 000 PLN

Balance sheet data of ENDOKRYNOLOGIA

Year
2018
2019
2021
2022
2023
Total assets 1 067 299,84 922 561,70 676 219,02 848 973,11 1 063 260,20
A. Fixed assets 125 101,66 197 461,77 181 465,69 158 631,19 53 703,19
B. Current assets 942 198,18 725 099,93 494 753,33 690 341,92 1 009 557,01
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 -
D. Own shares (stocks) 0,00 0,00 0,00 0,00 -
Total liabilities 1 067 299,84 922 561,70 676 219,02 848 973,11 1 063 260,20
A. Equity 977 591,64 837 048,74 505 424,54 616 235,65 849 917,04
B. Liabilities and provisions for liabilities 89 708,20 85 512,96 170 794,48 232 737,46 213 343,16
I. Long-term liabilities 0,00 0,00 13 500,00 0,00 0,00
II. Short-term liabilities 89 708,20 85 512,96 157 294,48 232 737,46 213 343,16
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.